References
- Swartz CM: Tardive psychopathology. Neuropsychobiology 1995; 32:115–119
- Cummings JL: Anatomic and behavioral aspects of frontal-subcortical circuits. Ann NY Acad Sci 1995; 769:1–13
- Podell K, Lovell M, Zimmerman M. Goldberg E: The cogni-tive bias task and lateralized frontal lobe functions in males. J Neuropsychiatry Clin Neurosci 1995; 7:491–501
- Seeman P, Tallerico T: Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 1998; 3:123–134
- Rich SS, Friedman JH, Ott BR: Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J Clin Psychiatry 1995; 56:556–559
- Potkin SG, Buchsbaum MS. Jin Y. Tang C, Telford J, Fried-man G, Lottenberg S. Najaf) A. Gulasekaram B, Costa J. et al.: Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry 1994; 55 (Suppl B):63–66
- Cohen RM, Nordahl TE, Semple WE, Andreason p, Litman RE, Pickar D: The brain metabolic patterns of clozapine-and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry 1997; 54:481–486
- Li XM, Perry KW, Wong DT, Bymaster FP: Olanzapine in-creases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psycho-pharmacology (Berlin) 1998; 136:153–161
- Robertson GS, Fibiger HC: Effects of olanzapine on regional c-Fos expression in rat forebrain. Neuropsychopharmacology 1996; 14:105–110